XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 (XYNPW)

CUSIP: 98421X110

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / *W EXP 05/15/202
Total 13F shares
923,368
Share change
+923,368
Total reported value
$195,000
Price per share
$0.21
Number of holders
12
Value change
+$195,000
Number of buys
12

Quarterly Holders Quick Answers

What is CUSIP 98421X110?
CUSIP 98421X110 identifies XYNPW - XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 (XYNPW) as of Q2 2019

As of 30 Jun 2019, XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 (XYNPW) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 923,368 shares. The largest 10 holders included Polar Asset Management Partners Inc., VR Advisory Services Ltd, Ionic Capital Management LLC, CNH PARTNERS LLC, Walleye Trading LLC, Context Capital Management, LLC, 683 Capital Management, LLC, Yakira Capital Management, Inc., COWEN INC., and Bulldog Investors, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.